story of the week
Pembrolizumab Plus Chemotherapy in Advanced Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
N. Engl. J. Med 2022 Jul 21;387(3)217-226, J Cortes, HS Rugo, DW Cescon, SA Im, MM Yusof, C Gallardo, O Lipatov, CH Barrios, J Perez-Garcia, H Iwata, N Masuda, M Torregroza Otero, E Gokmen, S Loi, Z Guo, X Zhou, V Karantza, W Pan, P SchmidFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.